CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Corticosteroids - topical (skin), nose, and eyes - Management
What should I consider when initiating intranasal corticosteroids?
- Intranasal corticosteroids are available as drops and sprays. The risk of systemic adverse effects is considered more likely with drops (as they are more likely to be administered incorrectly).
- The intranasal corticosteroids that are available in the UK are equally effective.
- However, for children, consider prescribing a preparation containing fluticasone propionate, mometasone, budesonide, or triamcinolone.
© NHS Institute for Innovation and Improvement